A Phase II Study of Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 25 Jul 2017
At a glance
- Drugs Paclitaxel (Primary) ; Cisplatin; Gemcitabine
- Indications Biliary cancer
- Focus Therapeutic Use
- 19 Jul 2017 Planned primary completion date changed from 1 Apr 2018 to 1 Apr 2019.
- 19 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 06 Jun 2017 Results (n=51) presented at the 53rd Annual Meeting of the American Society of Clinical Oncology